Cargando…

Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment

BACKGROUND: Exploration of cerebrospinal fluid (CSF) amino acids and the impact of dietary intake on central levels may provide a comprehensive understanding of the metabolic component of Alzheimer’s disease. OBJECTIVE: The objective of this exploratory study was to investigate the effects of two di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russin, Kate J., Nair, K. Sreekumaran, Montine, Thomas J., Baker, Laura D., Craft, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673538/ https://www.ncbi.nlm.nih.gov/pubmed/34602470 http://dx.doi.org/10.3233/JAD-210471

Ejemplares similares

Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimer’s Disease and Mild Cognitive Impairment
por: Hanson, Angela J., et al.
Publicado: (2023)

Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a randomized trial
por: Kellar, Derek, et al.
Publicado: (2022)

Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects
por: Coutinho, Artur M N, et al.
Publicado: (2015)

Biological Features of Reversion from Mild Cognitive Impairment to Normal Cognition: A Study of Cerebrospinal Fluid Markers and Brain Volume
por: Moradi, Kamyar, et al.
Publicado: (2021)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Ketogenic dietary lifestyle intervention effects on sleep, cognition, and behavior in mild cognitive impairment: Study design
por: Sanderlin, Ashley H., et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment
por: Hansen, Niels, et al.
Publicado: (2023)

Selenium Species in Cerebrospinal Fluid and Hippocampal Volume among Individuals with Mild Cognitive Impairment
por: Vinceti, Marco, et al.
Publicado: (2022)

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease
por: de la Monte, Suzanne M., et al.
Publicado: (2023)

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines
por: Ott, Brian R., et al.
Publicado: (2018)

Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment
por: Toledo, Jon B, et al.
Publicado: (2014)

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019)

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach
por: Cholerton, Brenna, et al.
Publicado: (2016)

A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
por: Vinceti, Marco, et al.
Publicado: (2017)

Cerebrospinal fluid and blood flow in mild cognitive impairment and Alzheimer's disease: a differential diagnosis from idiopathic normal pressure hydrocephalus
por: El Sankari, Soraya, et al.
Publicado: (2011)

Cerebrospinal Fluid MicroRNA Changes in Cognitively Normal Veterans With a History of Deployment-Associated Mild Traumatic Brain Injury
por: Lusardi, Theresa A., et al.
Publicado: (2021)

Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
por: Ashraf, Azhaar, et al.
Publicado: (2019)

Relationship between Cerebrospinal Fluid Matrix Metalloproteinases Levels and Brain Amyloid Deposition in Mild Cognitive Impairment
por: Sasaki, Yuuki, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults
por: Li, Ge, et al.
Publicado: (2017)

Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study
por: Kamalian, Aida, et al.
Publicado: (2023)

Diet–Cognition Associations Differ in Mild Cognitive Impairment Subtypes
por: Huang, Qiumin, et al.
Publicado: (2021)

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
por: Kaiser, Elmar, et al.
Publicado: (2011)

Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia
por: van Wijk, Nick, et al.
Publicado: (2017)

Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline
por: den Hoedt, Sandra, et al.
Publicado: (2023)

Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study
por: Nagpal, Ravinder, et al.
Publicado: (2020)

Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis
por: Michaud, Tzeyu L., et al.
Publicado: (2017)

Which part of the Quick mild cognitive impairment screen (Qmci) discriminates between normal cognition, mild cognitive impairment and dementia?
por: O'Caoimh, Rónán, et al.
Publicado: (2013)

Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment
por: Nagpal, Ravinder, et al.
Publicado: (2019)

Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study
por: Dhiman, Kunal, et al.
Publicado: (2022)

Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
por: Giau, Vo Van, et al.
Publicado: (2019)

Multiomics Analysis of Structural Magnetic Resonance Imaging of the Brain and Cerebrospinal Fluid Metabolomics in Cognitively Normal and Impaired Adults
por: Eldridge, Ronald C., et al.
Publicado: (2022)

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers
por: Gaetani, Lorenzo, et al.
Publicado: (2020)

ABCA1‐Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease
por: Yassine, Hussein N., et al.
Publicado: (2016)

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts
por: Tan, Lin, et al.
Publicado: (2016)

Small extracellular vesicles in plasma reveal molecular effects of modified Mediterranean-ketogenic diet in participants with mild cognitive impairment
por: Kumar, Ashish, et al.
Publicado: (2022)

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19
por: Apple, Alexandra C., et al.
Publicado: (2022)

Profile of Cognitive Complaints in Vascular Mild Cognitive Impairment and Mild Cognitive Impairment
por: Gu, Jenny, et al.
Publicado: (2013)

Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor and Cognitive Function in Non-Demented Subjects
por: Li, Ge, et al.
Publicado: (2009)

Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment
por: Hendriksz, Christian J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iov8h04pollkvgj6r562bvq51g